Bristol-Myers Squibb
BMY
BMY
2,145 hedge funds and large institutions have $95.4B invested in Bristol-Myers Squibb in 2020 Q1 according to their latest regulatory filings, with 144 funds opening new positions, 820 increasing their positions, 949 reducing their positions, and 179 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less capital invested
Capital invested by funds: $113B → $95.4B (-$17.7B)
20% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 179
25% less call options, than puts
Call options by funds: $1.42B | Put options by funds: $1.89B
Holders
2,145
Holding in Top 10
135
Calls
$1.42B
Puts
$1.89B
Top Buyers
| 1 | +$547M | |
| 2 | +$353M | |
| 3 | +$247M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$193M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$186M |
Top Sellers
| 1 | -$855M | |
| 2 | -$487M | |
| 3 | -$335M | |
| 4 |
Two Sigma Advisers
New York
|
-$325M |
| 5 |
RL
Ruffer LLP
London,
United Kingdom
|
-$276M |